Nifty
Sensex
:
:
11419.25
38337.01
-177.65 (-1.53%)
-560.45 (-1.44%)

Pharmaceuticals & Drugs

Rating :
42/99  (View)

BSE: 540222 | NSE: LAURUSLABS

351.45
1.20 (0.34%)
19-Jul-2019 | 3:57PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  353.90
  •  353.90
  •  350.00
  •  350.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  46581
  •  163.71
  •  472.00
  •  321.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,725.82
  • 39.74
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,758.73
  • 0.43%
  • 2.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.82%
  • 5.76%
  • 14.02%
  • FII
  • DII
  • Others
  • 0.03%
  • 30.84%
  • 16.53%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 11.56
  • 6.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.78
  • -2.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 6.60
  • -21.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 32.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.60

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
635.16
560.24
13.37%
529.46
478.93
10.55%
588.28
538.61
9.22%
539.02
491.22
9.73%
Expenses
523.17
443.36
18.00%
441.74
391.58
12.81%
512.56
426.04
20.31%
458.46
394.71
16.15%
EBITDA
111.99
116.88
-4.18%
87.71
87.35
0.41%
75.73
112.57
-32.73%
80.55
96.51
-16.54%
EBIDTM
17.63%
20.86%
16.57%
18.24%
12.87%
20.90%
14.94%
19.65%
Other Income
1.62
5.08
-68.11%
1.42
9.94
-85.71%
10.53
6.63
58.82%
2.59
7.54
-65.65%
Interest
17.57
23.26
-24.46%
23.65
17.76
33.16%
24.64
19.52
26.23%
22.32
19.10
16.86%
Depreciation
43.47
34.61
25.60%
42.71
30.98
37.86%
39.82
30.08
32.38%
38.19
29.79
28.20%
PBT
52.57
64.09
-17.97%
22.77
48.55
-53.10%
21.79
69.60
-68.69%
22.62
55.17
-59.00%
Tax
9.39
19.01
-50.60%
4.95
13.68
-63.82%
5.58
20.84
-73.22%
6.07
16.27
-62.69%
PAT
43.18
45.08
-4.21%
17.82
34.87
-48.90%
16.21
48.76
-66.76%
16.56
38.91
-57.44%
PATM
6.80%
8.05%
3.37%
7.28%
2.76%
9.05%
3.07%
7.92%
EPS
4.06
4.25
-4.47%
1.67
3.28
-49.09%
1.52
4.60
-66.96%
1.56
3.68
-57.61%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
-
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
-
11.47%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
-
1,224.80
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
-
1,067.12
1,000.15
915.36
777.43
505.32
439.29
GP Margin
-
46.56%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
-
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
109.37
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
4.77%
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
276.33
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
12.06%
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
178.96
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
7.81%
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
97.48
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
4.25%
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
31.96
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
1.39%
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
17.03
6.44
9.18
9.27
7.49
9.58
% Of Sales
-
0.74%
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
-
355.99
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
-
15.53%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
-
16.15
29.19
33.44
4.36
34.07
8.82
Interest
-
88.19
79.64
99.90
111.11
101.11
58.71
Depreciation
-
164.19
125.45
105.98
86.41
61.53
32.88
PBT
-
119.75
237.42
235.19
169.04
66.57
120.86
Tax
-
25.99
69.81
43.86
34.90
-1.55
23.64
Tax Rate
-
21.70%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
-
93.76
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
-
93.76
167.61
191.33
134.14
68.12
97.22
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
4.09%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
-
-44.06%
-12.40%
42.63%
96.92%
-29.93%
 
Unadjusted EPS
-
8.83
15.83
20.78
21.37
44.27
63.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,558.41
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
106.44
106.03
105.76
82.38
82.13
77.84
Total Reserves
1,446.60
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
295.49
174.30
132.34
428.11
363.73
203.92
Secured Loans
258.71
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
30.05
20.84
14.59
6.77
5.13
3.93
Current Liabilities
1,423.90
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
488.31
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
244.50
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
684.21
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
6.89
4.78
14.37
13.66
6.70
6.97
Total Liabilities
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
1,629.07
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
2,105.42
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
476.35
312.95
188.65
85.30
185.16
124.04
Non Current Assets
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
109.63
163.18
143.26
69.60
109.67
116.10
Non Current Investment
3.40
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
25.58
28.21
25.95
29.22
93.94
68.50
Other Non Current Assets
47.16
40.65
41.17
39.03
12.34
12.82
Current Assets
1,462.96
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
681.94
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
709.94
570.59
567.61
444.86
285.07
194.88
Cash & Bank
3.02
3.06
4.09
28.77
58.88
23.20
Other Current Assets
68.06
30.53
34.07
18.14
42.82
28.64
Short Term Loans & Adv.
35.22
58.63
25.01
23.86
22.75
19.80
Net Current Assets
39.05
-59.30
19.07
118.98
59.78
-136.06
Total Assets
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
297.66
342.49
331.99
181.97
-64.71
121.23
PBT
119.75
237.42
235.19
169.04
66.57
120.86
Adjustment
255.27
223.95
199.38
200.57
136.26
83.06
Changes in Working Capital
-52.04
-56.96
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
322.99
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-25.32
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-252.88
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
-6.57
-1.22
-24.40
-7.01
-18.65
Others
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
-44.77
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
0.02
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
3.00
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
2.97
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
145.91
139.28
125.25
499.30
419.61
189.14
ROA
3.00%
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
6.19%
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
8.22%
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.18
1.29
1.53
1.73
1.66
1.87
Receivable days
101.97
100.40
95.66
73.56
65.47
61.02
Inventory Days
100.87
96.48
94.12
97.00
109.61
102.73
Payable days
72.80
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
130.03
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.67
0.66
0.64
1.20
1.14
1.54
Interest Cover
2.36
3.98
3.35
2.52
1.66
3.06

News Update


  • USFDA completes inspection at Laurus Labs’ Unit 4 in Visakhapatnam
    12th Jul 2019, 15:27 PM

    The inspection was carried out from July 08, 2019-July 12, 2019

    Read More
  • USFDA completes inspection at Laurus Labs’ API facilities in Visakhapatnam
    14th Jun 2019, 16:45 PM

    This is a regular surveillance audit by USFDA, and no data integrity issues were observed in the inspection

    Read More
  • Laurus Labs reports marginal fall in Q4 consolidated net profit
    3rd May 2019, 12:39 PM

    The company has also reported fall of 5.18% in its standalone net profit for the quarter ended March 31, 2019

    Read More
  • Laurus Labs - Quarterly Results
    2nd May 2019, 17:26 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.